Pharma Business - August 27, 2025
Cereno Scientific granted FDA Fast Track Designation
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the company's lead program, CS1, for the treatment of pulmonary arterial hypertension (PAH).
Biotech Business - August 25, 2025
Leqembi launched in the EU – Austria and Germany will mark the first launches
BioArctic's partner Eisai has announced that the launch of Leqembi in the EU started in Austria on August 25, 2025, and will be launched in Germany on September 1, 2025.
Collaboration - August 19, 2025
Novo Nordisk and BioMed X launch new collaboration
The partnership aims to address the challenge of efficient oral delivery of therapeutic peptides.
Intellectual Property - August 18, 2025
Faron announces extension to key patent family with new US patent granted
Faron Pharmaceuticals has announced that the United States Patent and Trademark Office has granted a new US Patent for treatment of Clever-1 positive cancers with bexmarilimab and related structures that would bind to Clever-1 molecule for the wanted re-programming effect.
Agreement - August 11, 2025
Sever Pharma Solutions expands partnership with Silo Pharma
Under the new agreement, Sever Pharma Solutions will scale up extrusion processes and continue analytical testing for Silo’s investigational SP-26 ketamine-loaded polymer implant targeting chronic pain and fibromyalgia.
Agreement - August 11, 2025
Nanexa signs agreement with major pharma company
The company has announced the signing of an extension of a feasibility agreement with a major pharmaceutical company to investigate the use of Nanexa's PharmaShell platform for a specific drug with current yearly sales exceeding USD 1 billion.
